Correlation between serum phospholipid transfer protein activity levels and severity of coronary artery lesions in patients with coronary heart disease
CSTR:
Author:
Affiliation:

1.Department of Cardiology, Xishan People’s Hospital of Wuxi, Wuxi, Jiangsu 214011, China;2.Department of Cardiology, Zhongda Hospital of Southeast University, Nanjing, Jiangsu 210000, China)

Clc Number:

R543.3+1

  • Article
  • | |
  • Metrics
  • |
  • Reference [19]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    Aim To investigate the relationship between serum phospholipid transfer protein (PLTP) activity levels and severity of coronary artery lesions in patients with coronary heart disease (CHD). Methods 202 patients with chest pain were recruited in the Xishan People’s Hospital of Wuxi from June 2015 to June 2016, and these patients were divided into two groups based on coronary angiography (CHD group and non-CHD group). PLTP activity was measured with an assay kit, and the severity of coronary artery disease assessed by Gensini score was analyzed. Results PLTP activity levels and Gensini score in CHD group were significantly higher than that in non-CHD group (90.3(67~118)mg/dL vs 77.4 (54.6~103.3)mg/dL, P<0.05; 29(8~48) vs 2(0~6), P<0.001). PLTP activity levels and Gensini score were higher in patients aged 70~79 years old,male and diabetes than patients aged 60~69 years old, female and non-diabetes. Multiple linear regression analysis showed that PLTP activity levels were predictor for Gensini score after adjusting for the other risk factors (Beta=0.356, P<0.001). ROC curve was for PLTP activity levels to detect CHD patients with upper Gensini score quartile, and the area under the curve was 0.749(P<0.001). Conclusion Serum PLTP activity levels were predictive for the severity of coronary artery lesions in patients with CHD.

    Reference
    [1] Gensini G G.A more meaningful scoring system for determining the severity of coronary heart disease.Am J Cardiol, 3,1(3):606.
    [2] Fruchart J C, Davignon J, Hermans M P, et al.Residual macrovascular risk in 2013:what have we learned? .Cardiovasc Diabetol, 4,3:26.
    [3] Gross J J, Kessler E C, Albrecht C, et al.Response of the cholesterol metabolism to a negative energy balance in dairy cows depends on the lactational stage.PLoS One, 5,0(6):e0121956.
    [4] Vikstedt R, Ye D, Metso J, et al.Macrophage phospholipid transfer protein contributes significantly to total plasma phospholipid transfer activity and its deficiency leads to diminished atherosclerotic lesion development.Arterioscler Thromb Vasc Biol, 7,7(3):578-586.
    [5] Dullaart R P, Garcia E, Jeyarajah E, et al.Plasma phospholipid transfer protein activity is inversely associated with betaine in diabetic and non-diabetic subjects.Lipids Health Dis, 6,5(1):143.
    [6] Chen X, Sun A, Zou Y, et al.High PLTP activity is associated with depressed left ventricular systolic function.Atherosclerosis, 3,8(2):438-442.
    [7] Cavusoglu E, Marmur J D, Chhabra S, et al.Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography.Atherosclerosis, 9,7(1):261-265.
    [8] Van Linthout S, Hamdani N, Miteva K, et al.Placenta-derived adherent stromal cells improve diabetes mellitus-associated left ventricular diastolic performance.Stem Cells Transl Med, 7,6(12):2 135-145.
    [9] Pohlel K, Grow P, Helmy T, et al.Treating dyslipidemia in the elderly.Curr Opin Lipidol, 6,7(1):54-57.
    [10] Taravatmanesh S, Khalili D, Khodakarim S, et al.Determining the factors associated with cardiovascular disease recurrence:tehran lipid and glucose study.J Tehran Heart Cent, 7,2(3):107-113.
    [11] Yilmaz M, Altin C, Ozyildiz A, et al.Are oxidative stress markers helpful for diagnosing the disease and determining its complexity or extent in patients with stable coronary artery disease?.Turk Kardiyol Dern Ars, 7,5(7):599-605.
    [12] Frstermann U.Nitric oxide and oxidative stress in vascular disease.Pflugers Arch, 0,9(6):923-939.
    [13] Niccoli G, Giubilato S, Di Vito L, et al.Severity of coronary atherosclerosis in patients with a first acute coronary event:a diabetes paradox.Eur Heart J, 3,4(10):729-741.
    [14] Zornitzki T, Ayzenberg O, Gandelman G, et al.Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women.QJM, 7,0(9):575-581.
    [15] Desrumaux C, Deckert V, Lemaire-Ewing S, et al.Plasma phospholipid transfer protein deficiency in mice is associated with a reduced thrombotic response to acute intravascular oxidative stress.Arterioscler Thromb Vasc Biol, 0,0(12):2 452-457.
    [16] de Vries R, Kappelle P J, Dallinga-Thie GM, et al.Plasma phospholipid transfer protein activity is independently determined by obesity and insulin resistance in non-diabetic subjects.Atherosclerosis, 1,7(1):253-259.
    [17] Desrumaux C, Lemaire-Ewing S, Ogier N, et al.Plasma phospholipid transfer protein (PLTP) modulates adaptive immune functions through alternation of T helper cell polarization.Cell Mol Immunol, 6,3(6):795-804.
    [18] Zhang K, Liu X, Yu Y, et al.Phospholipid transfer protein destabilizes mouse atherosclerotic plaque.Arterioscler Thromb Vasc Biol, 4,4(12):2 537-544.
    [19] Yang X, Yu Y, Wang D, et al.Overexpressed PLTP in macrophage may promote cholesterol accumulation by prolonged endoplasmic reticulum stress.Med Hypotheses, 7,8:45-48.
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

CHEN Yi-Fei, JI Zhu-Jun, LI Xu-Dong, HUANG Yong-Xian, QIAN Zhong-Liang, QIU Jie-Yu, ZHU Xiao-Ming, LIU Nai-Feng. Correlation between serum phospholipid transfer protein activity levels and severity of coronary artery lesions in patients with coronary heart disease[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2018,26(6):621-625.

Copy
Share
Article Metrics
  • Abstract:938
  • PDF: 756
  • HTML: 0
  • Cited by: 0
History
  • Received:November 15,2017
  • Revised:April 17,2018
  • Online: July 10,2018
Article QR Code